Non-white subjects are underrepresented in phase III trials for psoriasis treatments

Plaque psoriasis is a common chronic inflammatory skin disease.  Treatment for plaque psoriasis includes oral systemic, topical, and biologic medications. Although biologic therapies continue to be increasingly utilized in treating moderate-to-severe psoriasis, evidence has shown that non-white ethnicity is associated with a reduced likelihood of responding to biologics up to one year in patients with …